FDA Approves IVIG for Dermatomyositis

(MedPage Today) -- The FDA approved intravenous immunoglobulins (IVIG; Octagam 10%) for treating adults with dermatomyositis, a rare chronic autoimmune disease, drugmaker Octapharma announced on Tuesday.
Support for the indication was based on...